Hyponatremia is a common medical problem and whilst previous research has shown an association with urinary retention, the prevalence of urinary retention in patients with hyponatremia has not been described. This prevalence is important clinical information when evaluating a patient with hyponatremia. Indeed, we found a significantly raised prevalence of urinary retention amongst patients with hyponatremia.
Interestingly, our control group of similar hospitalised patients had a markedly high prevalence of urinary retention of 21%. This high prevalence amongst unwell, bed restricted inpatients is worthy of investigation in future research.
Regarding our secondary aim of whether catheter insertion itself corrects hyponatraemia, our previous study [5] showed that in a small group of seven severely hyponatraemic patients, urinary catheter insertion led to a significantly increased sodium correction rate (9.6 ± 3mEq/L/48hours). Our current study did not demonstrate this difference. Notably, in patients with polyuria after catheter insertion, there was a significant sodium increase. Thus, polyuria could have been the cause of the improvement seen in the above study [5]. Consistent with this finding, a recent case series of three patients with severe hyponatraemia and urinary retention all had polyuria and a rapid sodium correction due to free water clearance and interventions were necessary to prevent the rapid increase of plasma sodium [1].
In our study, we could not isolate catheter insertion as an independent factor for correcting sodium level because everyone received standard hyponatremia treatment together with catheter insertion when needed. However, in a very small group of four patients for whom the only treatment was catheter insertion, the sodium correction was above average (10.8 mEq/L). This may be an important observation because these patients improved at an above average rate despite receiving no other treatment. Future research would investigate catheter insertion as the sole treatment for asymptomatic patients with hyponatraemia and urinary retention.
Concerning the main finding of increased prevalence of urinary retention in patients with hyponatraemia, we summarise several theories to explain the pathophysiology:
Hyponatremia in urinary retention could result from ADH secretion secondary to the pain of bladder distension in aUTO. Indeed, the prevalence of patients with SIADH in this group is 19 of the 41 (46%). There was no correlation between the volume of retention in patients with urinary retention to sodium level.
An alternative explanation may be “functional aUTO” where the hyponatraemia causes an altered conscious state in which the patient refrains from passing urine and thus develops urinary retention. Similarly, hypervolaemic hyponatraemic patients receiving diuretic therapy may find that the large urine volume and frequency make it impossible to mobilise to the lavatory and thus withhold urine output.
Additionally, patients experiencing decreased urinary output may drink more believing it will encourage urination and dilutional hyponatraemia. This itself may exacerbate hyponatraemia, as the therapeutic response would be to restrict water [3].
Further research to investigate the causes of urinary retention in hyponatraemia should be conducted. For example, the ADH theory could be tested by checking ADH levels in patients with different retention volumes.
This study was impressive for its large number of patients in the study and control groups. There was detailed clinical and laboratory data available for most patients in the study group. However, this was a descriptive study which did not allow for assessing the effect of interventions (for example assessing catheter insertion as a sole treatment) in a significant way.
In summary, there is a significantly higher prevalence of urinary retention in patients with hyponatremia which is associated with the severity of hyponatraemia. We recommend a routine bladder scan for all patients presenting with hyponatraemia. A significant predictor of rapid sodium correction is polyuria following urinary catheter insertion.
On behalf of all authors, the corresponding author states that there is no conflict of interest.
Table 1
The characteristics of patients according to sodium level
| Na < 126 mEq/L (n = 70) | Na126-129 mEq/L (n = 30) | Na < 130 mEq/L (n = 100) | Na ≥ 135 mEq/L (n = 99) | P value* |
Age (year), M (SD) | 84.4 (8.5) | 84.9 (7.9) | 84.6 (8.3) | 84 (8.4) | .618 |
Sex (male) (%) | 25 (36) | 8 (27) | 33 (33) | 45(45) | .098 |
Na (mEq/L), M (SD) | 119.8 (4.4) | 127.1 (1.2) | 122 (5.1) | 139.1 (2.7) | < 0.0005 |
Urinary retention (%),(mean volume ml) | 31 (44) (705) | 10 (33) (749) | 41 (41) (715) | 21 (21) (670) | .004 |
* Between research group (Na < 130) and compare group (Na ≥ 135 mEq/L) |
Table 2
–Hyponatraemic patients with and without urinary retention
Urinary retention | Yes (n = 41) | No (n = 59) | P value |
Age(year), M (SD) | 84.5 (8.5) | 84.7 (8.2) | .900 |
Sex, (male, N (%)) | 14 (34) | 19 (32) | 1.000 |
Comorbidities, N (%) | | | |
Diabetes mellitus | 13 (32) | 18 (31) | 1.000 |
Hypertension | 30 (73) | 46 (78) | .753 |
Congestive heart failure | 11 (27) | 19 (32) | .723 |
Cerebrovascular accident | 4 (10) | 9 (15) | .616 |
Chronic kidney disease | 9 (22) | 12 (20) | 1.000 |
Malignancy | 4 (10) | 9 (15) | .616 |
Hospitalization reason, N (%) | | | .945 |
Hyponatremia | 8 (20) | 14 (24) | |
Fall | 5 (12) | 7 (12) | |
Cardiovascular disease | 6 (15) | 11 (19) | |
Infection | 11 (27) | 14 (24) | |
Other | 11 (27) | 13 (22) | |
Medication, N (%) | | | |
Thiazide | 2 (5) | 4 (7) | 1.000 |
SSRI | 5 (12) | 5 (9) | .786 |
Opioids | 1 (2) | 4 (7) | .608 |
Volaemic status, N (%) | | | .215 |
Euvolaemic | 21 (51) | 25 (42) | |
Hypervolaemic | 12 (29) | 13 (22) | |
Hypovolaemic | 8 (20) | 21 (36) | |
Admission Na (mEq/L), Mean (SD) | 121 (5.56) | 123 (4.95) | .178 |
Admission NA ≤ 125, N(%) | 30 (73) | 36 (61) | .295 |
NA delta (mEq/L) (48 hours), M (SD) | 6.8 (5.4) | 6.1 (5.4) | .518 |
Volume retention (ml), M (SD) | 715(367) | 151(116) | < 0.005 |
Laboratory, M (SD) | | | |
Bun (mg/dL) | 30.7 (22.9) | 30.7 (24) | .994 |
Creatinine (mg/dL) | 1.4 (1.4) | 1.3 (1.2) | .762 |
Albumin (gr/dL) | 3.3 (0.5) | 3.2 (0.7) | .105 |
Potassium (mEq/L) | 4.2 (0.8) | 4.3 (0.7) | .549 |
Hemoglobin (g/dL) | 11.3 (1.8) | 10.9 (2.1) | .358 |
WBC (10ᶺ3/uL) | 11.2 (4.6) | 11.8 (14.8) | .820 |
Platelets (10ᶺ3/uL) | 288.5 (99.8) | 232.5 (89.7) | .004 |
TSH (mIU/L) | 3.1 (4.5) | 2.99 (3.5) | .952 |
Exitus, N (%) | 2 (5) | 8 (14) | .278 |
Treatment, N (%) | | | |
Saline 3% | 13 (32) | 18 (31) | 1.000 |
Water restriction | 7 (17) | 14 (24) | .580 |
Furosemide | 13 (32) | 20 (34) | .990 |
Drug withdrawal | 9 (22) | 14 (24) | 1.000 |
NaCl 0.9% | 30 (73) | 41 (70) | .861 |